Strategic Assay Selection for analytics in high-throughput process development: Case studies for downstream processing of monoclonal antibodies
Version of Record online: 24 SEP 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Special Issue: High-throughput process development
Volume 7, Issue 10, pages 1256–1268, October 2012
How to Cite
Konstantinidis, S., Kong, S., Chhatre, S., Velayudhan, A., Heldin, E. and Titchener-Hooker, N. (2012), Strategic Assay Selection for analytics in high-throughput process development: Case studies for downstream processing of monoclonal antibodies. Biotechnology Journal, 7: 1256–1268. doi: 10.1002/biot.201100476
- Issue online: 5 OCT 2012
- Version of Record online: 24 SEP 2012
- Accepted manuscript online: 8 AUG 2012 01:10AM EST
- Manuscript Accepted: 3 AUG 2012
- Manuscript Revised: 25 JUN 2012
- Manuscript Received: 2 APR 2012
- GE Healthcare
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.